


SOP 9: Monitoring of new regulations
The Monitoring of New Regulations SOP defines how regulatory updates are tracked, evaluated, and implemented to maintain continuous compliance.
It ensures your company stays aligned with evolving EMA, FDA, and ICH standards impacting GxP activities.
This SOP is fully written (≈ 98–99 % complete) and designed for biotech and life-science organizations managing multiple regulatory jurisdictions.
A structured regulatory-monitoring process minimizes compliance gaps and keeps your QMS current at all times.
What’s included
1 SOP: Serious Breaches
1 log form: Serious Breaches Assessment
✓ Editable Word documents✓ Prewritten GxP quality processes
✓ Ready for company specific customisation
✓ Designed to integrate with related QMS processes
✓ Suitable for paper based or electronic QMS implementation
Benefits
- Save weeks of documentation work
- Ensure consistent, GxP-aligned documentation
- Maintain controlled versions and effective dates
- Create traceable documentation and revision history
- Provide a scalable foundation for additional Quality processes
- Save weeks of documentation work
Suitable for
- Pharmaceutical companies building or expanding a QMS
- Early stage and growing regulated companies
- Virtual and highly outsourced companies
- Companies strengthening or standardising an existing Quality process
- Quality teams looking for ready to customise documentation
- Pharmaceutical companies building or expanding a QMS









_edited.png)






